Catyalyst Pharma (CPRX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.40 --0%
EPS Growth %: -30.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- GTA VI to catalyze a multi-year improvement in earnings power for TTWO, BTIG says
- CPI acquires TRISM instant issuance assets from HID Global
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
